|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Top Lists |
Insider Trading Graph View |
Insider Watch |
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise" - Peter Lynch ==>> What is insider trading>> |

| Transaction & Date | Reported Date |
Company | Symbol | Insider Relationship |
Shares Traded | Average Price | Total Amount |
Shares Ownership |
Filing |
| 2008-08-20 Sale |
2008-08-27 5:11 pm | SGX PHARMACEUTICALS, INC. | SGXP | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 5,507,674 | $3 | $16,523,022 | 0 (Indirect) |
View |
| 2008-08-20 Sale | 2008-08-22 5:29 pm | SGX PHARMACEUTICALS, INC. | SGXP | BAVP, L.P. (10% owner) | 2,546,747 | $3 | $7,640,241 | 0 (Direct) | View |
| 2008-08-20 Sale |
2008-08-22 5:28 pm |
SGX PHARMACEUTICALS, INC. | SGXP | BOCK LOUIS C (Director 10% owner) | 2,546,747 | $3 | $7,640,241 | 0 (Indirect) |
View |
| 2008-08-20 Sale |
2008-08-21 8:39 pm | SGX PHARMACEUTICALS, INC. | SGXP | EASTHAM KARIN (Director) | 12,500 | $3 | $37,500 | 0 (Direct) | View |
| 2008-08-20 Sale |
2008-08-21 8:38 pm | SGX PHARMACEUTICALS, INC. | SGXP | HENNEY CHRISTOPHER S (Director) | 97,165 | $3 | $291,495 | 0 (Direct) |
View |
| 2008-08-20 Sale |
2008-08-21 8:38 pm | SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 24,223 | $3 | $72,669 | 0 (Direct) |
View |
| 2008-08-20 Sale |
2008-08-21 8:37 pm | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 25,005 | $3 | $75,015 | 0 (Direct) | View |
| 2008-08-20 Sale | 2008-08-21 8:37 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 55,731 | $3 | $167,193 | 0 (Direct) | View |
| 2008-08-20 Sale | 2008-08-21 8:37 pm | SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 100,000 | $3 | $300,000 | 0 (Indirect) | View |
| 2008-08-15 Sale |
2008-08-18 3:47 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 781 | $2.98 | $2,327 | 24,223 (Direct) | View |
| 2008-08-05 Sale |
2008-08-06 1:01 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 781 | $2.96 | $2,312 | 25,005 (Direct) |
View |
| 2008-07-15 Sale |
2008-07-16 09:51 am |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 781 | $3.051 | $2,383 | 23,442 (Direct) |
View |
| 2008-07-08- -2008-07-11 Purchase |
2008-07-11 7:31 pm | SGX PHARMACEUTICALS, INC. | SGXP | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 1,298,100 | $3.035 | $3,939,900 | 5,507,674 (Indirect) | View |
| 2008-07-07 Sale |
2008-07-07 5:21 pm | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 781 | $1.6 | $1,250 | 24,223 (Direct) |
View |
| 2008-06-18 Purchase |
2008-06-20 4:21 pm |
SGX PHARMACEUTICALS, INC. | SGXP | BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP BVF INVESTMENTS LLC BVF INC (Indirect Beneficial Owner 10% owner) | 1,105,257 | $1.45 | $1,602,623 | 4,209,574 (Indirect) | View |
| 2008-06-16 Sale | 2008-06-17 1:44 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 781 | $1.65 | $1,289 | 22,660 (Direct) |
View |
| 2008-06-05 Sale | 2008-06-06 11:16 am |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 781 | $1.35 | $1,054 | 23,442 (Direct) |
View |
| 2008-05-15 Sale |
2008-05-15 8:58 pm | SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 781 | $1.45 | $1,132 | 21,879 (Direct) | View |
| 2008-05-05 Sale |
2008-05-06 3:00 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 781 | $1.43 | $1,117 | 22,660 (Direct) | View |
| 2008-04-15 Sale |
2008-04-16 2:20 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 781 | $1.19 | $929 | 21,097 (Direct) |
View |
| 2008-04-07 Sale |
2008-04-08 3:46 pm | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 781 | $1.335 | $1,042 | 21,879 (Direct) | View |
| 2008-03-17 Sale | 2008-03-18 3:37 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 781 | $4.01 | $3,132 | 20,316 (Direct) | View |
| 2008-03-05 Sale |
2008-03-05 2:37 pm | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 781 | $4.05 | $3,163 | 21,097 (Direct) |
View |
| 2006-02-01 Purchase | 2006-02-03 11:14 am | SGX PHARMACEUTICALS, INC. | SGXP | Atlas Venture Fund IV, L.P. Atlas Venture Parallel Fund IV-A, C.V. Atlas Venture Entrepreneurs Fund IV, L.P. Atlas Venture Associates IV, L.P. (10% owner) | 416,666 | $6 | $2,499,996 | 416,666 (Indirect) | View |
| Transaction & Date |
Reported Date | Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount | Shares Ownership |
Filing |
| 2008-08-15 Exercise | 2008-08-18 3:47 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,562 | $0 | $0 | 25,004 (Direct) |
View |
| 2008-08-05 Exercise | 2008-08-06 1:01 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,563 | $0 | $0 | 25,786 (Direct) | View |
| 2008-07-15 Exercise | 2008-07-16 09:51 am |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,563 | $0 | $0 | 24,223 (Direct) | View |
| 2008-07-07 Exercise |
2008-07-07 5:21 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,562 | $0 | $0 | 25,004 (Direct) |
View |
| 2008-06-16 Exercise |
2008-06-17 1:44 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,562 | $0 | $0 | 23,441 (Direct) | View |
| 2008-06-05 Exercise |
2008-06-06 11:16 am | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,563 | $0 | $0 | 24,223 (Direct) | View |
| 2008-05-15 Exercise | 2008-05-15 8:58 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,563 | $0 | $0 | 22,660 (Direct) |
View |
| 2008-05-05 Exercise | 2008-05-06 3:00 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,562 | $0 | $0 | 23,441 (Direct) | View |
| 2008-04-15 Exercise |
2008-04-16 2:20 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,562 | $0 | $0 | 21,878 (Direct) |
View |
| 2008-04-07 Exercise |
2008-04-08 3:46 pm | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,563 | $0 | $0 | 22,660 (Direct) |
View |
| 2008-03-17 Exercise |
2008-03-18 3:37 pm |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,563 | $0 | $0 | 21,097 (Direct) | View |
| 2008-03-05 Exercise | 2008-03-05 2:37 pm | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,562 | $0 | $0 | 21,878 (Direct) | View |
| 2006-02-06 Purchase | 2006-02-07 9:23 pm | SGX PHARMACEUTICALS, INC. | SGXP | Atlas Venture Fund IV, L.P. ATLAS VENTURE ASSOCIATES III L P ATLAS VENTURE ENTREPRENEURS FUND III L P Atlas Venture Parallel Fund IV-A, C.V. Atlas Venture Entrepreneurs Fund IV, L.P. Atlas Venture Associates IV, L.P. ATLAS VENTURE FUND III L P (10% owner) | 2,068,402 | $0 | $0 | 2,485,068 (Indirect) | View |
| 2006-02-06 Purchase | 2006-02-07 9:03 pm | SGX PHARMACEUTICALS, INC. | SGXP | PAPADOPOULOS STELIOS (Director) | 35,930 | $0 | $0 | 35,930 (Direct) |
View |
| Transaction & Date |
Reported Date |
Exercisable Expiration | Company | Symbol | Insider Relationship |
Shares Traded | Conversion Price | Shares Ownership | Filing |
| 2008-08-20 Option Sale | 2008-08-22 5:28 pm | N/A 2008-08-20 | SGX PHARMACEUTICALS, INC. | SGXP | BOCK LOUIS C (Director 10% owner) | 10,000 | $1.35 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-22 5:28 pm |
N/A 2008-08-20 | SGX PHARMACEUTICALS, INC. | SGXP | BOCK LOUIS C (Director 10% owner) | 10,000 | $5.03 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-22 5:28 pm | N/A 2008-08-20 |
SGX PHARMACEUTICALS, INC. | SGXP | BOCK LOUIS C (Director 10% owner) | 12,500 | $7.25 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:39 pm |
N/A 2018-06-04 |
SGX PHARMACEUTICALS, INC. | SGXP | TURNER JOSEPH L (Director) | 10,000 | $1.35 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:39 pm |
N/A 2017-12-12 |
SGX PHARMACEUTICALS, INC. | SGXP | TURNER JOSEPH L (Director) | 12,500 | $5 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:39 pm | N/A 2018-06-04 |
SGX PHARMACEUTICALS, INC. | SGXP | EASTHAM KARIN (Director) | 10,000 | $1.35 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:39 pm |
N/A 2017-05-16 | SGX PHARMACEUTICALS, INC. | SGXP | EASTHAM KARIN (Director) | 20,000 | $5.03 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm | N/A 2018-06-04 |
SGX PHARMACEUTICALS, INC. | SGXP | HENNEY CHRISTOPHER S (Director) | 20,000 | $1.35 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm | N/A 2017-05-16 | SGX PHARMACEUTICALS, INC. | SGXP | HENNEY CHRISTOPHER S (Director) | 25,000 | $5.03 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm |
N/A 2017-06-07 |
SGX PHARMACEUTICALS, INC. | SGXP | HENNEY CHRISTOPHER S (Director) | 30,000 | $5.21 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm |
N/A 2017-01-25 | SGX PHARMACEUTICALS, INC. | SGXP | RUGG TERENCE ANTHONY (CMO & VP, Drug Development) | 18,259 | $3.63 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm | N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | RUGG TERENCE ANTHONY (CMO & VP, Drug Development) | 7,627 | $3.99 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm |
N/A 2016-08-13 |
SGX PHARMACEUTICALS, INC. | SGXP | RUGG TERENCE ANTHONY (CMO & VP, Drug Development) | 71,052 | $4.75 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm |
N/A 2017-01-25 |
SGX PHARMACEUTICALS, INC. | SGXP | RUGG TERENCE ANTHONY (CMO & VP, Drug Development) | 31,741 | $3.63 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm |
N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | RUGG TERENCE ANTHONY (CMO & VP, Drug Development) | 18,523 | $3.99 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm | N/A 2016-08-13 | SGX PHARMACEUTICALS, INC. | SGXP | RUGG TERENCE ANTHONY (CMO & VP, Drug Development) | 3,948 | $4.75 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm |
N/A 2017-01-25 |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 34,559 | $3.63 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm |
N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 11,765 | $3.99 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm | N/A 2016-03-06 | SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 35,554 | $7.66 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm | N/A 2017-01-25 | SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 45,441 | $3.63 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm |
N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 21,485 | $3.99 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm |
N/A 2016-03-06 |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 4,446 | $7.66 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm |
N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 26,563 | $0 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm | N/A 2015-05-12 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 50,000 | $1 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm |
N/A 2017-01-25 | SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 24,511 | $3.63 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm |
N/A 2014-01-13 | SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 744 | $3.96 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm |
N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 18,011 | $3.99 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm | N/A 2016-03-06 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 40,462 | $7.66 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm |
N/A 2011-09-19 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 632 | $13.44 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm | N/A 2012-01-30 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 1,896 | $13.44 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm |
N/A 2012-07-30 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 948 | $13.44 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm | N/A 2013-06-04 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 632 | $13.44 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm | N/A 2017-01-25 | SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 25,489 | $3.63 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:38 pm | N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 15,239 | $3.99 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:38 pm | N/A 2016-03-06 | SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 19,538 | $7.66 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm | N/A 2017-01-25 | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 15,882 | $3.63 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm | N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 20,160 | $3.99 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm | N/A 2016-03-06 |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 41,179 | $7.66 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm |
N/A 2017-01-25 | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 34,118 | $3.63 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm |
N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 22,590 | $3.99 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm |
N/A 2016-03-06 |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 8,821 | $7.66 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm |
N/A N/A | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 25,000 | $0 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm |
N/A 2015-05-12 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 125,000 | $1 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm | N/A 2017-01-25 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 43,627 | $3.63 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm | N/A 2014-01-13 |
SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 2,003 | $3.96 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm |
N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 12,469 | $3.99 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm | N/A 2016-03-06 |
SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 33,086 | $7.66 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm |
N/A 2012-01-28 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 15,174 | $13.44 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm | N/A 2013-06-04 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 2,529 | $13.44 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm |
N/A 2011-05-03 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 6,175 | $1.58 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm |
N/A 2017-01-25 |
SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 56,373 | $3.63 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm |
N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 30,281 | $3.99 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm | N/A 2016-03-06 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 16,914 | $7.66 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm |
N/A 2011-05-03 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 12,351 | $13.44 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm | N/A 2012-01-28 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 1,777 | $13.44 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm |
N/A 2015-05-12 |
SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 263,863 | $1 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm |
N/A 2017-01-25 | SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 52,893 | $3.63 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm |
N/A 2014-01-13 | SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 2,383 | $3.96 | 0 (Direct) | View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm | N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 27,761 | $3.99 | 0 (Direct) |
View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm |
N/A 2016-03-06 | SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 26,228 | $7.66 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm | N/A 2013-06-04 | SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 5,058 | $13.44 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm |
N/A 2017-01-25 |
SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 97,107 | $3.63 | 0 (Direct) | View |
| 2008-08-20 Option Sale | 2008-08-21 8:37 pm | N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 105,239 | $3.99 | 0 (Direct) |
View |
| 2008-08-20 Option Sale |
2008-08-21 8:37 pm |
N/A 2016-03-06 | SGX PHARMACEUTICALS, INC. | SGXP | GREY MICHAEL G (President & CEO Director) | 53,772 | $7.66 | 0 (Direct) |
View |
| 2008-08-15 Exercise | 2008-08-18 3:47 pm |
N/A N/A | SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,562 | $0 | 26,563 (Direct) |
View |
| 2008-08-05 Exercise |
2008-08-06 1:01 pm |
N/A N/A | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,563 | $0 | 25,000 (Direct) |
View |
| 2008-07-15 Exercise |
2008-07-16 09:51 am | N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,563 | $0 | 28,125 (Direct) | View |
| 2008-07-07 Exercise |
2008-07-07 5:21 pm | N/A N/A | SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,562 | $0 | 26,563 (Direct) |
View |
| 2008-06-16 Exercise |
2008-06-17 1:44 pm | N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,562 | $0 | 29,688 (Direct) |
View |
| 2008-06-05 Option Award | 2008-06-12 4:46 pm |
N/A 2018-06-04 |
SGX PHARMACEUTICALS, INC. | SGXP | BOCK LOUIS C (Director 10% owner) | 10,000 | $1.35 | 10,000 (Direct) |
View |
| 2008-06-05 Option Award | 2008-06-11 3:07 pm |
N/A 2018-06-04 | SGX PHARMACEUTICALS, INC. | SGXP | HENNEY CHRISTOPHER S (Director) | 20,000 | $1.35 | 20,000 (Direct) |
View |
| 2008-06-05 Option Award | 2008-06-11 3:07 pm |
N/A 2018-06-04 |
SGX PHARMACEUTICALS, INC. | SGXP | TURNER JOSEPH L (Director) | 10,000 | $1.35 | 10,000 (Direct) | View |
| 2008-06-05 Option Award | 2008-06-11 3:04 pm |
N/A 2018-06-04 |
SGX PHARMACEUTICALS, INC. | SGXP | EASTHAM KARIN (Director) | 10,000 | $1.35 | 10,000 (Direct) | View |
| 2008-06-05 Exercise | 2008-06-06 11:16 am | N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,563 | $0 | 28,125 (Direct) | View |
| 2008-05-15 Exercise |
2008-05-15 8:58 pm | N/A N/A | SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,563 | $0 | 31,250 (Direct) | View |
| 2008-05-05 Exercise |
2008-05-06 3:00 pm | N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,562 | $0 | 29,688 (Direct) |
View |
| 2008-04-15 Exercise | 2008-04-16 2:20 pm |
N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,562 | $0 | 32,813 (Direct) |
View |
| 2008-04-07 Exercise |
2008-04-08 3:46 pm | N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,563 | $0 | 31,250 (Direct) | View |
| 2008-03-17 Exercise |
2008-03-18 3:37 pm |
N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 1,563 | $0 | 34,375 (Direct) |
View |
| 2008-03-05 Exercise | 2008-03-05 2:37 pm |
N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 1,562 | $0 | 32,813 (Direct) |
View |
| 2008-02-21 Option Award |
2008-02-25 5:17 pm | N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | RUGG TERENCE ANTHONY (CMO & VP, Drug Development) | 7,627 | $3.99 | 7,627 (Direct) | View |
| 2008-02-21 Option Award | 2008-02-25 5:17 pm |
N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | RUGG TERENCE ANTHONY (CMO & VP, Drug Development) | 18,523 | $3.99 | 18,523 (Direct) |
View |
| 2008-02-21 Option Award |
2008-02-25 5:17 pm |
N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 11,765 | $3.99 | 11,765 (Direct) |
View |
| 2008-02-21 Option Award |
2008-02-25 5:17 pm | N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | Reich Siegfried (VP, Drug Discovery) | 21,485 | $3.99 | 21,485 (Direct) | View |
| 2008-02-21 Option Award | 2008-02-25 5:17 pm |
N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 18,011 | $3.99 | 18,011 (Direct) | View |
| 2008-02-21 Option Award | 2008-02-25 5:17 pm |
N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | North Annette (General Counsel) | 15,239 | $3.99 | 15,239 (Direct) | View |
| 2008-02-21 Option Award | 2008-02-25 5:16 pm | N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 20,160 | $3.99 | 20,160 (Direct) | View |
| 2008-02-21 Option Award | 2008-02-25 5:16 pm | N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | Myers W Todd (CFO) | 22,590 | $3.99 | 22,590 (Direct) |
View |
| 2008-02-21 Option Award |
2008-02-25 5:16 pm |
N/A 2018-02-20 | SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 12,469 | $3.99 | 12,469 (Direct) |
View |
| 2008-02-21 Option Award |
2008-02-25 5:16 pm |
N/A 2018-02-20 |
SGX PHARMACEUTICALS, INC. | SGXP | Burley Stephen (CSO & SVP, Research) | 30,281 | $3.99 | 30,281 (Direct) |
View |
| 2007-05-17 Option Award |
2007-07-18 4:20 pm |
N/A 2017-05-16 |
SGX PHARMACEUTICALS, INC. | SGXP | FORMELA JEAN FRANCOIS (Director 10% owner) | 10,000 | $5.03 | 10,000 (Indirect) | View |
| 2007-05-17 Option Award |
2007-05-17 2:30 pm | N/A 2017-05-16 |
SGX PHARMACEUTICALS, INC. | SGXP | Lathi Vijay K (Director) | 10,000 | $5.03 | 10,000 (Direct) | View |
| 2006-02-06 Purchase |
2006-02-07 9:23 pm |
N/A N/A | SGX PHARMACEUTICALS, INC. | SGXP | Atlas Venture Fund IV, L.P. ATLAS VENTURE ASSOCIATES III L P ATLAS VENTURE ENTREPRENEURS FUND III L P Atlas Venture Parallel Fund IV-A, C.V. Atlas Venture Entrepreneurs Fund IV, L.P. Atlas Venture Associates IV, L.P. ATLAS VENTURE FUND III L P (10% owner) | 3,352,836 | $0 | 0 (Indirect) | View |
| 2006-02-06 Purchase |
2006-02-07 9:23 pm | N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | Atlas Venture Fund IV, L.P. ATLAS VENTURE ASSOCIATES III L P ATLAS VENTURE ENTREPRENEURS FUND III L P Atlas Venture Parallel Fund IV-A, C.V. Atlas Venture Entrepreneurs Fund IV, L.P. Atlas Venture Associates IV, L.P. ATLAS VENTURE FUND III L P (10% owner) | 783,968 | $0 | 0 (Indirect) |
View |
| 2006-02-06 Purchase |
2006-02-07 9:03 pm |
N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | PAPADOPOULOS STELIOS (Director) | 58,234 | $0 | 0 (Direct) | View |
| 2006-02-06 Purchase |
2006-02-07 9:03 pm | N/A N/A |
SGX PHARMACEUTICALS, INC. | SGXP | PAPADOPOULOS STELIOS (Director) | 13,626 | $0 | 0 (Direct) | View |
|
© 2005-2009 SecForm4.Com All rights reserved. Archives: 2009 2008 2007 2006 2005 2004 ... Sat, 21 Nov 2009 15:42:21 -0600 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC. SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |